02696.HK
Shanghai Henlius Biotech, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 49.06
−1.72%Forward multiples
Based on analyst estimates
- P/E forward
- 17.04x
- P/E 2026E
- 20.57x
- P/E 2027E
- 22.72x
- P/E 2028E
- 17.23x
- P/S forward
- 1.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- 26.24x
- PEG TTM
- 0.49x
- Price / book
- 5.00x
- Price / sales
- 3.05x
- Price / cash flow
- 27.84x
Enterprise value
- Enterprise value
- HKD 30.2B
- EV / sales
- 3.45x
- EV / EBITDA
- 20.24x
- EV / EBIT
- 28.63x
- Market cap
- HKD 26.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026